SHARE:  
Join Our Email List
CTSI Update: Submit Your Applications Today
CTSI Career Development Program
KL2 Fellowship Funding
NOI Deadline: Dec.15, 2022

We are delighted to announce that the BU CTSI will support One (1) KL2 scholar for a Career Development Award. The two-year appointment will be effective as of April 1, 2023,
to March 31, 2025. Learn More
Advance Gender Equity for Women in the Biomedical Sciences
Proposals Deadline: Nov. 15, 2022

We seek innovative scholarly biomedical research or educational projects conducted by faculty in the Chobanian & Avedisian SOM, College of Arts and Sciences and College of Engineering. Learn More.
BU CTSI NIH Diversity Supplement
Matching Initiative
Fill out an Interest Form

The BU CTSI is committed to increasing our institution’s biomedical researcher diversity by connecting eligible early career scientists with Principal Investigators who have grants eligible for Diversity Supplements. Learn More
The BU CTSI Voucher Program
Applications are Accepted on a Rolling Basis.

This Program supports the short-term needs of investigators that are not otherwise covered by grants. Vouchers are intended to enable preliminary work, generate data for new or ongoing projects, and/or secure fee-based core services for consultation services. Learn More
Funding Opportunities

Notice of Special Interest (NOSI) Targeting Epigenetic Regulators for Treating Addiction and Substance Use Disorders


Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03)


Notice of Special Interest (NOSI): Chemoproteomic Approaches for Discovery of Targets and Therapeutics to Treat Substance Use Disorders

National Institute on Drug Abuse (NIDA)

Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed)

National Cancer Institute (NCI)

Notice of Special Interest (NOSI): Supporting Data Sciences Research in IDeA States through the Centers of Biomedical Research Excellence (COBRE) Phase 1 Program

National Institute of General Medical Sciences (NIGMS)

Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed)

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

Notice of Special Interest (NOSI): Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior

Office of Research on Women's Health (ORWH)

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Notice of Special Interest (NOSI): Research through NCATS’ Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)

National Center for Advancing Translational Sciences (NCATS)

HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional)

National Institute of Neurological Disorders and Stroke (NINDS)
News Highlights

New N3C Effort to Speed COVID-19
Public Health Answers

Researchers can submit proposals to use electronic health record data from the National COVID Cohort Collaborative (N3C) to answer important public health questions.
Upcoming Event

International Collaborations:
Policies, Processes, & Partnerships
Nov. 9, 2022, 11 am–3:30 pm

Don’t miss this engaging and informative time with NIH experts as they share resources and knowledge during the presentations, case studies, and live Q&A. Learn More
The Funding Acknowledgement
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.